María José Fernández

ORCID: 0000-0002-2186-4380
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ethics in Clinical Research
  • Lymphoma Diagnosis and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Public Health and Environmental Issues
  • Child and Adolescent Psychosocial and Emotional Development
  • Chronic Lymphocytic Leukemia Research
  • Nursing care and research
  • Health and Medical Education
  • Biomedical Ethics and Regulation
  • COVID-19 Clinical Research Studies
  • Respiratory Support and Mechanisms
  • Cancer Diagnosis and Treatment
  • Pharmaceutical industry and healthcare
  • Interpreting and Communication in Healthcare
  • Financial Distress and Bankruptcy Prediction
  • Trigeminal Neuralgia and Treatments
  • Sympathectomy and Hyperhidrosis Treatments
  • Intraperitoneal and Appendiceal Malignancies
  • Occupational and environmental lung diseases
  • Blood properties and coagulation
  • Neuroendocrine Tumor Research Advances
  • BRCA gene mutations in cancer
  • Hepatitis Viruses Studies and Epidemiology
  • Cardiac pacing and defibrillation studies
  • Health Literacy and Information Accessibility

Clínica CES
2021-2025

Beth Israel Deaconess Medical Center
2023-2024

Harvard University
2023-2024

Sociedade Brasileira de Oncologia Clínica
2023

Universidad CES
2021-2022

Hadassah Medical Center
2022

Mayo Clinic in Florida
2019-2020

Institución Universitaria Escolme
2019

Jacksonville College
2019

WinnMed
2019

This study aimed to analyze the direct healthcare costs and early complications associated with pretransplant portal vein thrombosis (PVT) in cirrhotic patients undergoing their first orthotopic liver transplant (LT) at a hospital Colombia from 2013 2021. A registry-based retrospective follow-up was conducted on aged 14 years or older who underwent LT San Vicente Fundación Rionegro Hospital between January April The primary outcomes were (30-day) vascular biliary costs. generalized linear...

10.1016/j.vhri.2024.101070 article EN cc-by-nc-nd Value in Health Regional Issues 2025-01-15

Abstract The association between pre-existing cardiovascular disease (CVD) and the development of adverse events (CVAE) during Bruton tyrosine kinase inhibitor (BTKi) therapy is not well established. We compared rate CVAE, such as new onset or worsening atrial fibrillation (AF), supraventricular tachycardia, ventricular hypertension, myocardial infarction, sudden cardiac death, individuals with without CVD, BTKi treatment. Secondary objectives were to compare outcomes patients treated first...

10.1093/oncolo/oyae229 article EN cc-by-nc The Oncologist 2024-09-08

Comprehensive protein analyses of plasma are made possible by high-throughput proteomic screens, which may help find new therapeutic targets and diagnostic biomarkers. Patients with cancer frequently affected venous thromboembolism (VTE). The limited predictive accuracy current VTE risk assessment tools highlights the need for new, more targeted Although coagulation biomarkers diagnosis, prognosis, treatment have been investigated, none them necessary clinical validation or accuracy....

10.4081/btvb.2024.120 article EN cc-by-nc Bleeding Thrombosis and Vascular Biology 2024-05-16

Purpose: This is the first report of an institutional-based cancer registry in Clínica de Oncología Astorga, Medellín, Colombia. It was created to produce local information on socio-demographic and clinical characteristics, therapies, survival outcomes patients with most frequent tumors institution. Methods: All consecutive cancers breast (BC), prostate (PC), lung (LC), colorectal (CRC), ovarian, stomach, pancreas, cervical, melanoma, diagnosed after January 1/2019, treated at institution...

10.51643/22562915.517 article EN cc-by-nc-nd Revista Colombiana de Hematología y Oncología 2023-08-03

e17008 Background: Relugolix is a novel oral GnRH antagonist that now an alternative option for patients with prostate cancer (PC) who require androgen deprivation therapy (ADT). The potential benefits of relugolix include rapid testosterone decline and recovery, administration, possible cardiovascular (CV) benefit compared to traditional agonists. This study examines real-world data on prescribing practices clinical experiences at large, urban academic center. Methods: We conducted...

10.1200/jco.2024.42.16_suppl.e17008 article EN Journal of Clinical Oncology 2024-06-01

ResumenObjetivo:Determinar el ceod en escolares de 6 años la parroquia El Sagrario-Cuenca año 2016.Materiales y Métodos: Se realizó un estudio tipo descriptivo, transversal, retrospectivo; muestra estuvo constituida 163 fichas epidemiológicas correspondientes a pacientes años, los cuales 55% correspondió al sexo femenino 45% masculino, pertenecientes escuelas fiscales Sagrario.Resultados: Los resultados obtenidos mostraron que índice poblacional Sagrario fue 4,7, cual no tuvo diferencias...

10.24265/kiru.2019.v16n1.04 article ES Kiru 2019-03-31

This theoretical study examines the main findings and researches regarding comorbidity between conduct disorder major depression in adolescence. On one hand, it is argued that high prevalence of imply common risk factors (biological, cognitive- emotional socio-cultural) a causal relationship these mental illness, usually preceding depression. other independent nosological status this "comorbidity" advocated on basis several external criteria (e.g. response to treatment, course into adulthood...

10.5944/rppc.vol.14.num.1.2009.4062 article EN cc-by-nc-nd Revista de Psicopatología y Psicología Clínica 2009-04-01

El cáncer de próstata es una enfermedad prevalente, generadora gran morbimortalidad y reportada como la quinta causa muerte a nivel mundial. Según las estimaciones GLOBOCAN (Global Cancer Observatory por sus siglas en inglés) para el año 2018 se reportaron 1 276 106 casos nuevos Recientemente, surgen los microARN posible estrategia futura biomarcadores, tanto diagnóstico tratamiento enfermedad. Los son pequeñas moléculas ARN que cumplen un papel regulación expresión génica, lo variable estas...

10.21615/cesmedicina.35.1.3 article ES CES Medicina 2021-05-04

6553 Background: Patients (pts) from historically underrepresented groups often have limited English proficiency (LEP). One challenge specific to obtaining consent these pts participate in clinical trials is the need for translated CDs. CD translation leads enrollment delays and increases costs study sponsors. We hypothesized that NISS, which principal investigator pays costs, would proportionately fewer with a primary language other than LEP compared industry sponsored studies (ISS)....

10.1200/jco.2023.41.16_suppl.6553 article EN Journal of Clinical Oncology 2023-06-01

Objetivo: La prueba genómica de recurrencia 21 genes (Oncotype DX, Genomic Health) (ODx®) permite determinar la utilidad quimioterapia adyuvante en pacientes con cáncer mama temprano tipo luminal. De forma segura se puede omitir un puntaje riesgo bajo (RB). También han desarrollado otros modelos predictivos basados variables clínicas e histopatológicas estándar. Estos incluyen las ecuaciones Magee (EM), el modelo Predict (MP) y puntuación del nomograma Tennessee (NT). El objetivo este...

10.51643/22562915.620 article ES cc-by-nc-nd Revista Colombiana de Hematología y Oncología 2023-06-28
Coming Soon ...